Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb–drug interactions in antiviral therapy

Jingyin granules, a marketed antiviral herbal medicine, have been recommended for treating H1N1 influenza A virus infection and Coronavirus disease 2019 (COVID-19) in China. To fight viral diseases in a more efficient way, Jingyin granules are frequently co-administered in clinical settings with a v...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Feng, Liu, Wei, Huang, Jian, Chen, Qi-long, Wang, Dan-dan, Zou, Li-wei, Zhao, Yong-fang, Zhang, Wei-dong, Xu, Jian-guang, Chen, Hong-zhuan, Ge, Guang-bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237038/
https://www.ncbi.nlm.nih.gov/pubmed/34183756
http://dx.doi.org/10.1038/s41401-021-00697-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237038/
https://www.ncbi.nlm.nih.gov/pubmed/34183756
http://dx.doi.org/10.1038/s41401-021-00697-2

Ejemplares similares